Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BMEAthis companyBiomea Fusion, Inc.	$0.60	-1.05×	2.19×	0×	-0.17×	48.4%	0.0%	0.0%	0.0%	-209.1%	-166.2%	-108.7%	0.05×	0.9×	0×	5.23×	0.0%	0	-18.95	2	C+
ALXOALX Oncology Holdings Inc.	$1.22	-0.59×	2.33×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-391.4%	-262.0%	-139.1%	0.2×	0.11×	-64.93×	2.07×	0.0%	2	-2.66	2	C
CAMPCAMP4 Therapeutics Corporation	$4.34	-2.31×	3.9×	53.24×	-1.56×	-1164.1%	53.1%	-1488.3%	-2298.5%	-168.5%	-50.8%	-16.0%	0.04×	2.13×	0×	7.35×	0.0%	1	-5.32	2	C
CBUSCibus, Inc.	$1.25	-0.63×	3.65×	21.88×	-3.72×	-625.8%	-62.8%	-1853.9%	-3492.3%	-582.2%	-23.2%	-64.3%	12.28×	-2.84×	-1.9×	0.72×	0.0%	3	-4.45	1	D+
GUTSFractyl Health, Inc.	$0.89	-2.39×	35.68×	0×	-2.27×	52.9%	0.0%	0.0%	0.0%	-1490.3%	-89.5%	-26.9%	6.52×	0.14×	0×	4.78×	0.0%	2	-13.45	2	C+
IMUXImmunic, Inc.	$8.02	-0.86×	-12.46×	0×	-0.7×	-91.8%	0.0%	0.0%	0.0%	1456.2%	1693.4%	-103.4%	-0.1×	0.15×	0×	0.75×	0.0%	2	-5.39	2	C
Peer median	—	-0.86×	3.65×	0×	-1.56×	-91.8%	0.0%	0.0%	0.0%	-391.4%	-50.8%	-64.3%	0.2×	0.14×	0×	2.07×	0.0%	2	-5.32	2	—